3′-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide

This publication has 12 references indexed in Scilit:

• Antisense oligonucleotide therapeutics: drug delivery and targeting
  Advanced Drug Delivery Reviews, 1996
• Investigation of the labelling characteristics of 99mTc-mercaptoacetyltriglycine
  Nuclear Medicine and Biology, 1995
• Expression of Ca²⁺‐binding proteins of the S100 family in malignant human breast‐cancer cell lines and biopsy samples
  International Journal of Cancer, 1994
• Development of Antisense Therapeutics: Implications for Cancer Gene Therapy
  Annals of the New York Academy of Sciences, 1994
• Antisense Oligonucleotides as Therapeutic Agents—Is the Bullet Really Magical?
  Science, 1993
• Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for the two previously unreported calcium-binding proteins S100D and S100E.
  Proceedings of the National Academy of Sciences, 1993
• Current concepts in antisense drug design
  Journal of Medicinal Chemistry, 1993
• Modified deoxyoligonucleotides stable to exonuclease degradation in serum
  Nucleic Acids Research, 1991
• Antisense oligonucleotides: a new therapeutic principle
  Chemical Reviews, 1990
• Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family.
  Genes & Development, 1989